Page 1 of Clinical Trials for "Cadexomer iodine", 283 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma
Last Updated: April 19, 2012
Condition(s): Lymphoma, Non-Hodgkin
2
Active, not recruiting
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate
Last Updated: June 29, 2011
Condition(s): Prostate Cancer
3
Recruiting
Study of Chlorhexidine Gluconate as a Preoperative Antisepsis
Last Updated: December 15, 2011
Condition(s): Surgical Site Infection
4
Recruiting
Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation
Last Updated: April 26, 2010
Condition(s): Surgical Site Infection
5
Completed
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
Last Updated: August 10, 2010
Condition(s): Viral Conjunctivitis
6
Active, not recruiting
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Last Updated: February 29, 2012
Condition(s): Thyroid Cancer
7
Completed
Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Last Updated: February 9, 2012
Condition(s): Lymphoma, Non-Hodgkin; Non-Hodgkin's Lymphoma
8
Terminated
Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma
Last Updated: December 9, 2010
Condition(s): Lymphoma, Non-Hodgkin; Non-Hodgkin's Lymphoma
9
Completed
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
Last Updated: February 22, 2011
Condition(s): Thyroid Neoplasms
10
Not yet recruiting
The Counter-irritating Efficacy of Topical Povidone-iodine in Thermal Burns
Last Updated: May 9, 2011
Condition(s): Skin Burns
11
Active, not recruiting
Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Last Updated: October 5, 2011
Condition(s): Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
12
Active, not recruiting
Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
Last Updated: October 7, 2011
Condition(s): Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
13
Active, not recruiting
Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody
Last Updated: July 16, 2009
Condition(s): Non-Hodgkin's Lymphoma
14
No longer available
Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Last Updated: July 16, 2009
Condition(s): Non-Hodgkin's Lymphoma
15
Recruiting
Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development
Last Updated: November 13, 2008
Condition(s): Iodine Deficiency; Infant Development
16
Active, not recruiting
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Last Updated: March 29, 2012
Condition(s): Lymphoma, Mantle-Cell
17
Recruiting
A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine
Last Updated: May 27, 2011
Condition(s): Fungal Keratitis; Infected Corneal Ulcers
18
Completed
A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)
Last Updated: April 3, 2012
Condition(s): Lymphoma, Non-Hodgkin
19
Active, not recruiting
Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Last Updated: March 23, 2012
Condition(s): Lymphoma
20
Recruiting
The Use of Diluted Povidone Iodine Irrigation in Spine Surgery
Last Updated: April 12, 2012
Condition(s): Surgical Site Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Cadexomer+iodine%22

Page 1 of Clinical Trials for "Cadexomer iodine", 283 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About